Search for: "Hyman Phelps McNamara"
Results 21 - 40
of 426
Sorted by Relevance
|
Sort by Date
6 Dec 2010, 11:14 pm
Hyman, Phelps & McNamara’s Paul Hyman and Ricardo Carvajal recently published an article in Food Chemical News on the cost of inadequate substantiation of health-related claims made in the labeling and advertising of foods. [read post]
3 Aug 2011, 2:40 pm
In his recent article appearing in FDLI Update, Hyman, Phelps & McNamara, P.C.’s Douglas B. [read post]
14 Jul 2010, 5:00 pm
Hyman, Phelps & McNamara, P.C. [read post]
2 Feb 2011, 3:31 pm
In his recent article appearing in FDLI Update, Hyman, Phelps & McNamara, P.C. [read post]
12 Aug 2018, 7:18 pm
By Hyman, Phelps & McNamara, P.C. [read post]
22 Nov 2011, 7:51 pm
In his recent article appearing in FDLI Update, Hyman, Phelps & McNamara, P.C. [read post]
16 May 2016, 10:27 am
The FDA Law Blog is pleased to announce the release of the FDA Deskbook, prepared by the attorneys at Hyman, Phelps & McNamara, P.C., the same authors who provide the expertise and analysis contained in this blog. [read post]
5 Oct 2010, 10:49 am
Hyman, Phelps & McNamara, P.C.’s Kurt R. [read post]
10 Nov 2014, 8:28 pm
Hyman, Phelps & McNamara, P.C. has once again been ranked as a “Tier 1” law firm in the area of “FDA Law” (both nationally and in Washington, D.C.) by the folks over at U.S. [read post]
23 Feb 2012, 4:11 pm
Gibbs – On February 15, 2012, Hyman, Phelps & McNamara, P.C. [read post]
4 Nov 2012, 11:35 pm
Frank Sasinowki, Director at Hyman, Phelps & McNamara, P.C. and board member of the National Organization for Rare Disorders ("NORD"), is giving the keynote address for the Campaign Urging Research for Eosinophilic Disease’s ("CURED’s") first research symposium on eosinophilic gastrointestinal disorders ("EGID"). [read post]
4 Nov 2012, 11:35 pm
Frank Sasinowki, Director at Hyman, Phelps & McNamara, P.C. and board member of the National Organization for Rare Disorders ("NORD"), is giving the keynote address for the Campaign Urging Research for Eosinophilic Disease’s ("CURED’s") first research symposium on eosinophilic gastrointestinal disorders ("EGID"). [read post]
8 Nov 2011, 6:08 am
For the second year in a row, Hyman, Phelps & McNamara, P.C. has been ranked as a “Tier 1” law firm in the area of FDA Law (both nationally and in Washington DC) by the folks over at U.S. [read post]
8 Nov 2018, 3:20 pm
By Hyman, Phelps & McNamara, P.C. [read post]
8 Feb 2013, 2:32 pm
On January 31, 2013, Hyman, Phelps & McNamara, P.C. presented a webinar addressing the real-world implications from the Second Circuit decision in United States v. [read post]
20 Sep 2010, 10:28 am
Hyman, Phelps & McNamara, P.C. [read post]
4 Dec 2012, 7:21 pm
Hyman, Phelps & McNamara, P.C., the nation’s largest boutique food and drug regulatory law firm, seeks an associate with three to six years experience in medical device law and regulation to assist with a growing practice. [read post]
17 May 2011, 1:44 pm
In his recent article appearing in FDLI Update, Hyman, Phelps & McNamara, P.C. [read post]
20 Sep 2011, 11:10 am
Hyman, Phelps & McNamara, P.C.’s Ricardo Carvajal will be presenting at the following upcoming conferences on food law and policy. [read post]
18 Sep 2011, 9:45 am
Wolszon – On August 31, Hyman, Phelps & McNamara, P.C. [read post]
